trending Market Intelligence /marketintelligence/en/news-insights/trending/KxkDR66GvM9dI-DDyio4cA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Immunotec fiscal Q1 profit falls YOY


M&A rebound sparks optimism for near-term deal activity


Fintech Intelligence Newsletter: February 2021


Q&A: Navigating Climate Risk as a Financial Risk


Bundling fixed & mobile services is still a popular strategy for operators in Western Europe especially in Portugal and Spain

Immunotec fiscal Q1 profit falls YOY

Immunotec Inc. said its normalized net income for the fiscal first quarter ended Jan. 31 came to C$345,650, a decrease of 57.7% from C$817,260 in the prior-year period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin declined to 1.5% from 4.6% in the year-earlier period.

Total revenue climbed 28.0% year over year to C$22.9 million from C$17.9 million, and total operating expenses increased 32.0% from the prior-year period to C$22.4 million from C$17.0 million.

Reported net income declined 58.1% on an annual basis to C$346,450, or 0 cents per share, from C$827,270, or 1 cents per share.